• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Quantitative analysis of mutant p53 protein in breast tumor cytosols and study of its association with other biochemical prognostic indicators in breast cancer.

作者信息

Levesque M A, Diamandis E P, Yu H, Sutherland D J

机构信息

Department of Clinical Biochemistry, Toronto Western Division, Toronto Hospital, Ontario, Canada.

出版信息

Breast Cancer Res Treat. 1994;30(2):179-95. doi: 10.1007/BF00666062.

DOI:10.1007/BF00666062
PMID:7524772
Abstract

Breast tumors are thought to originate, grow, and metastasize in an environment which includes steroid hormone receptors, their cognate steroid ligands, and many gene products which are regulated by steroid hormone receptor-ligand complexes. In this paper we describe highly sensitive and quantitative immunofluorometric procedures for measuring three proteins that are candidate prognostic indicators in breast cancer, namely, the p53 tumor suppressor gene product, carcinoembryonic antigen (CEA), and prostate specific antigen (PSA). These proteins were quantified in over 950 cytosolic tumor extracts along with estrogen and progesterone receptors (ER, PR). Association analysis between all five biochemical parameters revealed strong negative associations between p53 and receptors and strong positive associations between CEA and receptors. Negative associations between p53 and CEA and between CEA and PSA were also found. These associations, not quantitatively studied in previous reports, are related to each other using a hypothetical model. The observed associations may further contribute to the understanding of the biology of breast tumors.

摘要

相似文献

1
Quantitative analysis of mutant p53 protein in breast tumor cytosols and study of its association with other biochemical prognostic indicators in breast cancer.
Breast Cancer Res Treat. 1994;30(2):179-95. doi: 10.1007/BF00666062.
2
Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators.乳腺肿瘤中p53蛋白和前列腺特异性抗原的免疫荧光分析及其与其他预后指标的关联。
Br J Cancer. 1995 Sep;72(3):720-7. doi: 10.1038/bjc.1995.400.
3
Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age.女性和男性乳腺肿瘤中免疫反应性前列腺特异性抗原水平及其与类固醇激素受体和患者年龄的关联。
Clin Biochem. 1994 Apr;27(2):75-9. doi: 10.1016/0009-9120(94)90015-9.
4
Detection of prostate-specific antigen immunoreactivity in breast tumors.
Breast Cancer Res Treat. 1994;32(3):301-10. doi: 10.1007/BF00666007.
5
Comparison of cytosolic p53 protein levels in the female genital tract and breast, and their tumors.女性生殖道和乳腺及其肿瘤中细胞溶质p53蛋白水平的比较。
Tumour Biol. 2000 May-Jun;21(3):123-34. doi: 10.1159/000030118.
6
Prognostic significance of p53 overexpression in primary breast cancer; a novel luminometric immunoassay applicable on steroid receptor cytosols.原发性乳腺癌中p53过表达的预后意义;一种适用于类固醇受体胞质溶胶的新型发光免疫测定法。
Br J Cancer. 1995 May;71(5):1013-7. doi: 10.1038/bjc.1995.195.
7
[Determination of prostate-specific antigen (PSA) in cytosol of breast tumors and human endometrium--new diagnostic approaches].
Zentralbl Gynakol. 1998;120(4):172-5.
8
Carcinoembryonic antigen and steroid receptors in the cytosol of carcinoma of the breast. Relationship to pathologic and clinical features.乳腺癌细胞溶质中的癌胚抗原和类固醇受体。与病理及临床特征的关系。
Cancer. 1985 May 15;55(10):2464-71. doi: 10.1002/1097-0142(19850515)55:10<2464::aid-cncr2820551026>3.0.co;2-w.
9
Relationship between p53 expression and other prognostic factors in human breast carcinoma. An immunohistochemical study.人乳腺癌中p53表达与其他预后因素的关系。一项免疫组织化学研究。
Am J Clin Pathol. 1993 Sep;100(3):213-7. doi: 10.1093/ajcp/100.3.213.
10
Analysis of cytosol CA15-3, carcinoembryonic antigen, estrogen and progesterone receptors in breast cancer tissues.乳腺癌组织中细胞溶质CA15-3、癌胚抗原、雌激素和孕激素受体的分析。
Jpn J Cancer Res. 1992 Feb;83(2):171-7. doi: 10.1111/j.1349-7006.1992.tb00083.x.

引用本文的文献

1
Resveratrol, through NF-Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor alpha gene expression via p38MAPK/CK2 signaling in human breast cancer cells.白藜芦醇通过 NF-Y/p53/Sin3/HDAC1 复合物磷酸化,通过 p38MAPK/CK2 信号通路抑制人乳腺癌细胞中雌激素受体 α 基因的表达。
FASEB J. 2011 Oct;25(10):3695-707. doi: 10.1096/fj.10-178871. Epub 2011 Jul 7.
2
Tissue carcinoembryonic antigen and oestrogen receptor status in breast carcinoma: an immunohistochemical study of clinical outcome in a series of 252 patients with long-term follow-up.乳腺癌组织中的癌胚抗原和雌激素受体状态:对252例患者进行长期随访的临床结果免疫组织化学研究
Br J Cancer. 1998 May;77(10):1661-8. doi: 10.1038/bjc.1998.273.
3

本文引用的文献

1
P53 and cathepsin-d are independent of established prognostic factors in breast-cancer.P53和组织蛋白酶D与乳腺癌已确定的预后因素无关。
Int J Oncol. 1992 Oct;1(5):507-12. doi: 10.3892/ijo.1.5.507.
2
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
3
Quantification of p53 protein in tumor cell lines, breast tissue extracts and serum with time-resolved immunofluorometry.采用时间分辨免疫荧光分析法对肿瘤细胞系、乳腺组织提取物及血清中的p53蛋白进行定量分析。
A novel quantitative immunoassay system for p53 using antibodies selected for optimum designation of p53 status.
一种新型的p53定量免疫分析系统,该系统使用为优化p53状态判定而选择的抗体。
J Clin Pathol. 1997 Feb;50(2):143-7. doi: 10.1136/jcp.50.2.143.
4
Quantification of prostate-specific antigen immunoreactivity in human breast cyst fluids.
Breast Cancer Res Treat. 1996;38(3):247-52. doi: 10.1007/BF01806142.
5
Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators.乳腺肿瘤中p53蛋白和前列腺特异性抗原的免疫荧光分析及其与其他预后指标的关联。
Br J Cancer. 1995 Sep;72(3):720-7. doi: 10.1038/bjc.1995.400.
Oncogene. 1993 Jun;8(6):1501-9.
4
p53 is required for radiation-induced apoptosis in mouse thymocytes.p53是小鼠胸腺细胞辐射诱导凋亡所必需的。
Nature. 1993 Apr 29;362(6423):847-9. doi: 10.1038/362847a0.
5
Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer.p53蛋白表达与淋巴结阴性乳腺癌肿瘤细胞增殖率及临床结局的相关性
J Natl Cancer Inst. 1993 Feb 3;85(3):200-6. doi: 10.1093/jnci/85.3.200.
6
Ultrasensitive time-resolved immunofluorometric assay of prostate-specific antigen in serum and preliminary clinical studies.血清中前列腺特异性抗原的超敏时间分辨免疫荧光分析及初步临床研究。
Clin Chem. 1993 Oct;39(10):2108-14.
7
Detection of prostate-specific antigen immunoreactivity in breast tumors.
Breast Cancer Res Treat. 1994;32(3):301-10. doi: 10.1007/BF00666007.
8
Relationships of S-phase fraction of breast carcinoma in relapse to duration of remission, estrogen receptor content, therapeutic responsiveness, and duration of survival.
Cancer Res. 1980 Jun;40(6):1890-6.
9
Monoclonal antibodies to human estrogen receptor.抗人雌激素受体单克隆抗体。
Proc Natl Acad Sci U S A. 1980 Sep;77(9):5115-9. doi: 10.1073/pnas.77.9.5115.
10
CEA-like material in cytosols from human breast carcinomas. Correlation with biochemical and pathologic parameters.
Cancer. 1983 Jan 1;51(1):121-3. doi: 10.1002/1097-0142(19830101)51:1<121::aid-cncr2820510124>3.0.co;2-l.